Author

Sailaja Bhaskar

Observed name: Bhaskar, Sailaja

Institution: Intellia Therapeutics (United States)

Observed institutions: George Washington University, Purdue Pharma (United States), Intellia Therapeutics (United States)

ORCID: 0000-0003-2495-4602

Observed ORCID: 0000-0003-2495-4602

OpenAlex ID: A5028305849

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

2013 · James A. Simon, David J. Portman, et al. · Menopause The Journal of The North American Menopause Society · 149

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

2014 · JoAnn V. Pinkerton, Hadine Joffe, et al. · Menopause The Journal of The North American Menopause Society · 50

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

2014 · David J. Portman, Andrew M. Kaunitz, et al. · Menopause The Journal of The North American Menopause Society · 30

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study

2020 · Ann C. Childress, Matthew N. Brams, et al. · Journal of Child and Adolescent Psychopharmacology · 21

In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse

2022 · Manjunath Shet, Jonna Westover, et al. · BMC Oral Health · 15

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD

2022 · Marc Cataldo, Graeme Donnelly, et al. · Journal of Attention Disorders · 10

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD

2021 · Ann Childress, Andrew J. Cutler, et al. · Journal of Attention Disorders · 10

In Vitro Evaluation of the Virucidal Activity of Different Povidone–Iodine Formulations Against Murine and Human Coronaviruses

2021 · Manjunath Shet, Rosa Hong, et al. · Infectious Diseases and Therapy · 8

A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD

2024 · Vishal Madaan, Sailaja Bhaskar, et al. · Journal of Attention Disorders · 6

Pharmacokinetic Properties of Once-Daily Oral Low-Dose Mesylate Salt of Paroxetine (LDMP 7.5 mg) Following Single and Multiple Doses in Healthy Postmenopausal Women

2013 · M. Cristina Castelli, Sailaja Bhaskar, et al. · Clinical Therapeutics · 4

Evaluation of dermal toxicity and toxicokinetics of povidone‑iodine in Göttingen minipigs

2023 · Evangeline Priya Eddy, Manjunath S. Shet, et al. · Toxicology and Applied Pharmacology · 3

5.8 Comparison of Adhansia XR and Concerta Pharmacokinetic Profiles

2021 · Graeme Donnelly, Rachelle Rodriguez, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1

An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults

2026 · Margaret D. Weiss, Jeffrey H. Newcorn, et al. · Journal of Attention Disorders

Safety Profile of Paroxetine 7.5 mg in Women With Moderate-to-Severe Vasomotor Symptoms

2014 · James A. Simon, David J. Portman, et al. · Obstetrics and Gynecology

Defining Non-Inferiority Margins for Skin Adhesion Studies

2014 · Marina Komaroff, Sailaja Bhaskar

Works count: 27

Citation count: 307

H-index: 8

I10-index: 7